Iovance Biotherapeutics
IOVA
IOVA
272 hedge funds and large institutions have $3.22B invested in Iovance Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 90 increasing their positions, 82 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
272
Holders Change
+37
Holders Change %
+15.74%
% of All Funds
3.94%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
70
Increased
90
Reduced
82
Closed
33
Calls
$93.8M
Puts
$31.4M
Net Calls
+$62.4M
Net Calls Change
+$27.6M
Top Buyers
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$154M |
| 2 |
2
Morgan Stanley
New York
|
$39.9M |
| 3 |
3
Balyasny Asset Management
Chicago,
Illinois
|
$17.8M |
| 4 |
O
4
OrbiMed
New York
|
$0 |
| 5 |
5
Pictet Asset Management
Carouge,
Switzerland
|
$47.5M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
301
Belvedere Trading
Chicago,
Illinois
| – | -$35.1K | -4,323 | Closed |
|
|
BWM
302
BKM Wealth Management
Brookfield,
Wisconsin
| – | -$4.63K | -570 | Closed |
|
|
GWS
303
Glassman Wealth Services
Vienna,
Virginia
| – | -$951 | -117 | Closed |
|
|
SA
304
Scarborough Advisors
Annapolis,
Maryland
| – | -$49 | -6 | Closed |
|